RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 100-110
  • Allergan is in merger talks with Irish pharmaceutical firm Actavis

    Allergan is in merger talks with Irish pharmaceutical firm Actavis
    Botox maker Allergan Inc. of Irvine, which has spent six months fighting a hostile takeover attempt by a Canadian company, is in increasingly serious discussions to merge with Irish pharmaceutical firm Actavis. If Allergan agrees to be acquired by...
  • Arrowhead Research seeks to reassure antsy investors

    Arrowhead Research seeks to reassure antsy investors
    Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases. The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
  • Local company develops training products for self-injection

    Local company develops training products for self-injection
    Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis. Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
  • Allergan sale to Actavis thwarts takeover attempt by Valeant

    Allergan sale to Actavis thwarts takeover attempt by Valeant
    Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion. The deal thwarts a...
  • Ingredion predicts $8 billion in sales by 2019

     Ingredion predicts $8 billion in sales by 2019
    Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets. The announcement comes weeks after...
  • The Medicine Cabinet-Ask the Harvard Experts: With even some generics rising in price, explore ways to cut your drug costs

    Q: Recently, my doctor prescribed a 10-day course of doxycycline. I always ask for a generic since I need to pay full price. I was shocked when the pharmacist said it would be almost $65. I took this medication three years ago and I think it cost me...
  • Generic drug prices skyrocket in past year

     Generic drug prices skyrocket in past year
    After calling for a routine prescription refill, Craig Elliott got a rude shock: His bill was going up fivefold. The 44-year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his...
  • Though cheered by Wall Street, most mergers don't work out for buyers

    — Wall Street's big business — helping companies buy other companies — is hotter than it's been in years. When pharmaceuticals giant Actavis said it was buying Allergan Inc. in Irvine and Halliburton said it would take over rival oil-...
  • Allergan likely to lose bid to stop takeover by Valeant, analyst says

    Allergan likely to lose bid to stop takeover by Valeant, analyst says
    Botox maker Allergan Inc. of Irvine appears increasingly likely to be acquired by a Canadian rival, an analyst said Tuesday. Valeant Pharmaceuticals International Inc. has been working for five months to acquire Allergan and its coveted lineup of beauty...
  • Payments to doctors from drug companies, device makers revealed

    Payments to doctors from drug companies, device makers revealed
    Late last year, medical device maker Zimmer Holdings Inc. made two large payments to Dr. Andrew N. Pollak, chair of the University of Maryland Medical System's orthopedics department. The payments, one for $47,225 and the other for $45,902, were...
  • Pacific Pact Could Hurt Drug Innovation, Drug Makers

    Pacific Pact Could Hurt Drug Innovation, Drug Makers
    This month, negotiations over the Trans-Pacific Partnership resume in Australia. Officials from the United States and 11 other major economies are meeting to settle the final details of the trade pact, with the hope of passing the final deal by year's...